Detalle Publicación

ENGOT-Ov41/GEICO-69-O/ANITA trial: A phase Ill randomized, double-blinded trial of platinum-based chemotherapy (CT) with or without atezolizumab (ATZ) followed by niraparib maintenance with or without ATZ in patients with recurrent ovarian, tubal or peritoneal cancer (OC) and platinum treatment-free interval (TFIp) > 6 months.

Autores: González Martín, Antonio; Colombo, N. ; Heitz, F. ; Christensen, R. D. ; Selle, F.; Vergote, I. ; Oaknin, A.

Título de la revista: JOURNAL OF CLINICAL ONCOLOGY

ISSN: 0732-183X

Volumen: 37

Número: 15

Páginas: TPS5599-TPS5599

Fecha de publicación: 2019

DOI: https://doi.org/10.1200/JCO.2019.37.15_suppl.TPS5599

Impacto:

Google Scholar